We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s Medicines and Healthcare products Regulatory Agency has given its blessing to AstraZeneca's Tagrisso as part of the Early Access to Medicines Scheme. Read More
Given safety risks and weaker evidence in some patients, the FDA says it is questioning whether positive findings reported for Teva’s asthma drug reslizumab are enough to warrant approval. Read More
The Department of Justice has netted $96 million from the pharmaceutical industry in settlements and judgments from civil cases involving fraud and false claims against the government in the fiscal year ending Sept. 30. Read More